BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

830 related articles for article (PubMed ID: 15256389)

  • 1. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study.
    Bateman ED; Boushey HA; Bousquet J; Busse WW; Clark TJ; Pauwels RA; Pedersen SE;
    Am J Respir Crit Care Med; 2004 Oct; 170(8):836-44. PubMed ID: 15256389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Is guideline-defined asthma control achievable?--secondary publication. The Gaining Optimal Asthma ControL (GOAL) Study].
    Pedersen SE
    Ugeskr Laeger; 2005 Sep; 167(38):3595-7. PubMed ID: 16219190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial.
    Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening AP; Haahtela T; Holgate ST; Picado C; Menten J; Dass SB; Leff JA; Polos PG
    BMJ; 2003 Oct; 327(7420):891. PubMed ID: 14563743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
    Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: a randomized, double-blind, multicenter study.
    Ilowite J; Webb R; Friedman B; Kerwin E; Bird SR; Hustad CM; Edelman JM
    Ann Allergy Asthma Immunol; 2004 Jun; 92(6):641-8. PubMed ID: 15237766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
    Murray J; Rosenthal R; Somerville L; Blake K; House K; Baitinger L; VanderMeer A; Dorinsky P
    Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower inhaled steroid requirement with a fluticasone/salmeterol combination in family practice patients with asthma or COPD.
    Schermer TR; Albers JM; Verblackt HW; Costongs RJ; Westers P
    Fam Pract; 2007 Apr; 24(2):181-8. PubMed ID: 17251178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
    Galant SP; van Bavel J; Finn A; Gross G; Pleskow W; Brown A; Hamedani AG; Harding SM
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
    Baumgarten C; Geldszus R; Behre U; Peslis N; Trautmann M;
    Eur J Med Res; 2002 Jan; 7(1):1-7. PubMed ID: 11827834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast.
    Nelson HS; Busse WW; Kerwin E; Church N; Emmett A; Rickard K; Knobil K
    J Allergy Clin Immunol; 2000 Dec; 106(6):1088-95. PubMed ID: 11112891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers.
    Chapman KR; Ringdal N; Backer V; Palmqvist M; Saarelainen S; Briggs M
    Can Respir J; 1999; 6(1):45-51. PubMed ID: 10202220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined salmeterol 50 microg and fluticasone propionate 250 microg in the diskus device for the treatment of asthma.
    Shapiro G; Lumry W; Wolfe J; Given J; White MV; Woodring A; Baitinger L; House K; Prillaman B; Shah T
    Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 1):527-34. PubMed ID: 10673196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: an analysis of asthma exacerbations.
    Matz J; Emmett A; Rickard K; Kalberg C
    J Allergy Clin Immunol; 2001 May; 107(5):783-9. PubMed ID: 11344343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma?
    Koenig SM; Murray JJ; Wolfe J; Andersen L; Yancey S; Prillaman B; Stauffer J; Dorinsky P
    Respir Med; 2008 May; 102(5):665-73. PubMed ID: 18328683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma.
    Masoli M; Weatherall M; Holt S; Beasley R
    Thorax; 2005 Sep; 60(9):730-4. PubMed ID: 16135679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbations.
    Ferguson GT; Anzueto A; Fei R; Emmett A; Knobil K; Kalberg C
    Respir Med; 2008 Aug; 102(8):1099-108. PubMed ID: 18614347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of Asthma in School age Children On Therapy (MASCOT): a randomised, double-blind, placebo-controlled, parallel study of efficacy and safety.
    Lenney W; McKay AJ; Tudur Smith C; Williamson PR; James M; Price D;
    Health Technol Assess; 2013 Feb; 17(4):1-218. PubMed ID: 23380178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy salmeterol/fluticasone versus doubling dose of fluticasone in children with asthma.
    Vaessen-Verberne AA; van den Berg NJ; van Nierop JC; Brackel HJ; Gerrits GP; Hop WC; Duiverman EJ;
    Am J Respir Crit Care Med; 2010 Nov; 182(10):1221-7. PubMed ID: 20622031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.